Interleukin 8 and tumor necrosis factor-α level in acute rheumatic fever and chronic rheumatic heart disease
DOI:
https://doi.org/10.54361/ljmr.v8i1.07Abstract
Forty children were included in this study with age ranging between 5 - 15 years. They were divided into four groups according to clinical presentation. Group I with acute rheumatic arthritis, group II with chorea, group III with clinical carditis and group IV with chronic heart disease. Twenty healthy children were investigated for IL-8 and TNF-α as a control group. We found that the serum level of IL-8 was significantly higher than the control group and in carditis than arthritis. TNF-α was significantly higher in acute rheumatic fever than control group. The result showed that the level of IL-8 and TNF-α were significantly higher in patients with chorea than arthritis. These parameters also were significantly higher in rheumatic chorea than chronic rheumatic heart disease. The recurrence of rheumatic activity and development of chronic rheumatic heart disease was high in patients with high levels of interleukins in acute phase.
References
Robinson JH and Kehoe MA. Group A streptococcal M. protein: virulence factors and protective antigens. Immunol Today. 1992, 13: 362-367. DOI: https://doi.org/10.1016/0167-5699(92)90173-5
Nordet P. WHO/95FC. Global program for prevention and control of RF/RHD J Int Suc Fed Cardiol. 1993, 3: 4-5.
Eisenberg MJ. Rheumatic heart disease in developing world. Eur Heart J. 1993, 14: 122-128. DOI: https://doi.org/10.1093/eurheartj/14.1.122
Gibofsky A and Zabriskie JB. Rheumatic fever and poststreptococcal reactive arthritis. Curr Opin Rheumatic. 1995, 7; 4: 299-305. DOI: https://doi.org/10.1097/00002281-199507000-00006
Samsonov MI, Tilz GP, Piskalakove VP and Wadrter H. Serum soluble receptors for TNF-α, IL-2, and neoptrin in rheumatic fever. Clin Immunol Immunopathol. 1995, 74; 1: 31-34. DOI: https://doi.org/10.1006/clin.1995.1005
Wotanabe OR, Aclon J and Tomai MA. Characterization of unique human TCR, BB specificities for a family of streptococcal superantigen, represented by rheumatogenic serotype of M-protein. J Immunol. 1994, 152: 2066-2073. DOI: https://doi.org/10.4049/jimmunol.152.4.2066
Narin N, KutuKculer N, Bakiler AR and Parlar A. Lymphocyte subset and IL-1, IL-2, and TNF-α concentration in acute rheumatic fever and chronic heart disease. Clin Immunopathol. 1995, 77; 2: 172-176. DOI: https://doi.org/10.1006/clin.1995.1140
Baggiolini M. J Clin Invest. 1989, 84: 1045-1049. DOI: https://doi.org/10.1172/JCI114265
Eichbaum, QG, Hugher EJ, Epsttein SE and Beatty DW. Rheumatic fever autoantibodies against a variety of cardiac, nuclear and streptococcal antigens. Ann Rheum Dis. 1995, 54; 9: 746. DOI: https://doi.org/10.1136/ard.54.9.740
Morris K, Mohan C and Gangaly NK. Enhancement of IL-1, IL-2, production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease, a prospective study. Clin Exp Immunol. 1993, 91; 3: 429-436. DOI: https://doi.org/10.1111/j.1365-2249.1993.tb05920.x
Kuter Kcuer N. Plasma interleukins in acute rheumatic fever and chronic rheumatic heart disease Scand J Rheumatol. 1995, 24; 6: 383-385. DOI: https://doi.org/10.3109/03009749509095185
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Wafa Benzabya (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
